Published in Nature Communications: MiNK Therapeutics’ AgenT-797 Demonstrates Promising Results in the Treatment of Severe Acute Respiratory Distress

MiNK Therapeutics in the NEWS 
Today, February 6, 2024, MiNK Therapeutics (INKT) announced the publication of the results in Nature Communications from phase 1/2 study of agenT-797 . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.